Date: 2015-06-22
Type of information: Nomination
Compound:
Company: Santhera Pharmaceuticals (Switzerland)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On June 22, 2015, Santhera Pharmaceuticals announced the appointment of Christoph Rentsch as Chief Financial Officer with effect from July 1, 2015. Christoph Rentsch started his career in investment banking at Credit Suisse. Subsequently, he worked for Lonza both in Switzerland and the US. Thereafter he joined Roche as Head of Group Funding and Capital Markets for several years before he became partner of Caperis Ltd, an investment advisory and management firm. Since 2010 he served as CFO of privately-held Polyphor, where he led several financing rounds and supported the company in key stages of its development. Christoph Rentsch holds a degree in economics and business administration from the University of Applied Sciences, Basel.
Financial terms:
Latest news:
